Latest News & Features
Big Pharma
Courts on both sides of the Atlantic recorded a flurry of settlements this week, as Astellas, GSK, and Alexion drew a line under long-running disputes with generic rivals. 11 February 2026
Americas
Telehealth platform faces legal action from the Danish pharma giant, as well as FDA pressure over GLP-1 drugs and a drop in shares after discontinuing new product. 10 February 2026
Americas
The Swiss pharma giant moves to protect patents on its billion-dollar cancer therapy following an ANDA filing by a Canadian generics manufacturer. 9 February 2026
Americas
A Delhi High Court ruling signals more bad news for the Danish pharma giant in the same week that it lost nearly $50 billion in value. 6 February 2026
Careers
The New York-based partner will advise biotech, pharma, and technology clients on patent prosecution, IP strategy and venture-backed transactions. 6 February 2026
Asia
The British-Swedish pharma giant pays $1.2 billion upfront for access to next-generation weight-loss treatment as China patent cliff changes the market. 5 February 2026
Europe
Excitement is mounting for the world’s largest IP gathering, which will see the industry’s elites travelling to the UK in the spring, reveals the association’s CEO. 5 February 2026
Careers
The trial group, which brings “exceptional litigation talent”, joins larger firm in Texas and Washington, DC, coinciding with the announcement of the Winston Taylor merger. 5 February 2026
Careers
The new hire, who has clients in pharma and medical devices and diagnostics, will lead the Dublin office's IP & Technology practice. 4 February 2026
Americas
Nominations are open for the Life Sciences Patent Network's 2026 awards in Boston, including six new categories and winners selected by leading industry experts. 3 February 2026